| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/10/2006 | WO2006083936A2 Anti-ephb2 antibodies and methods using same |
| 08/10/2006 | WO2006083799A2 Suspending vehicles comprising a hydrophilic solvent, a hydrophobic solvent, a polymer and the suitable pump-driven dosage form |
| 08/10/2006 | WO2006083761A2 Solvent/polymer solutions as suspension vehicles |
| 08/10/2006 | WO2006083562A2 Method and multicomponent conjugates for treating cancer |
| 08/10/2006 | WO2006083276A2 Interferon-alpha polypeptides and conjugates |
| 08/10/2006 | WO2006083260A2 Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use |
| 08/10/2006 | WO2006083001A1 Method of measuring coating amount and method of estimating elution behavior |
| 08/10/2006 | WO2006082888A1 Percutaneous absorption preparation |
| 08/10/2006 | WO2006082842A1 Hard capsule having improved solubility |
| 08/10/2006 | WO2006082824A1 Matrix-type enteric coated sustained release composition |
| 08/10/2006 | WO2006082728A1 Transdermal absorption patch |
| 08/10/2006 | WO2006082530A2 Conjugation of streptococcal capsular saccharides to carrier proteins |
| 08/10/2006 | WO2006082517A1 Pyy agonists and uses thereof |
| 08/10/2006 | WO2006082490A1 Injectable formulations of benzimidazole compounds |
| 08/10/2006 | WO2006082451A1 Bioactive compounds |
| 08/10/2006 | WO2006082184A2 Conjugates of a polypeptide and a pentasaccharide |
| 08/10/2006 | WO2006066020A3 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 08/10/2006 | WO2006047714A3 Sustained release of active molecules from polymers topically applied to skin or hair |
| 08/10/2006 | WO2006026471A3 Compositions and methods to lower glycohemoglobin levels |
| 08/10/2006 | WO2005123114A3 Silk-based drug delivery system |
| 08/10/2006 | WO2005121215A3 Polypeptides with the capacity to entrap drugs and release them in a controlled way |
| 08/10/2006 | WO2005117843A3 Sustained release preparations |
| 08/10/2006 | WO2005115473A3 Nutritional food and feed, composition, processing and method of use |
| 08/10/2006 | WO2005099768A3 Polymeric prodrug with a self-immolative linker |
| 08/10/2006 | WO2004105694A3 Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs |
| 08/10/2006 | US20060178505 Thioester-terminated water soluble polymers and method of modifying the N-terminus of a polypeptide therewith |
| 08/10/2006 | US20060178501 PYY agonists and use thereof |
| 08/10/2006 | US20060178475 Branched polymers and their conjugates |
| 08/10/2006 | US20060178474 Activating polyethylene glycol; reacting with multi-functional linking moiety; quenching; deprotecting, neutralization, reacting with biologically active moiety such as drug, polypeptide, protein |
| 08/10/2006 | US20060178336 Oral administration of therapeutic agent coupled to transporting agent induces tolerance |
| 08/10/2006 | US20060178313 Use of a polypeptide for treatment of pruritus in animals |
| 08/10/2006 | US20060178310 Intracellular delivery of biological effectors |
| 08/10/2006 | US20060178295 androgen steroid conjugated with one or more mammalian proteins; diagnosis or treatment of solid cancer and hematological malignancies; exhibit a synergistic action together with a cytoskeleton-acting drug such as Taxol (reg); prostate cancer |
| 08/10/2006 | US20060177901 Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy |
| 08/10/2006 | US20060177892 Intracellular formation of peptide conjugates |
| 08/10/2006 | US20060177810 Method of inhibiting freeze concentrating of substance in wet material, method of inhibiting deactivation of physiologically active substance, and process for producing lyophilizate or frozen matter having component homogeneously diffused therein |
| 08/10/2006 | US20060177524 Ocular irrigating solution |
| 08/10/2006 | US20060177523 Administration of a thiol-based chemoprotectant compound |
| 08/10/2006 | US20060177514 Preparation of a therapeutic composition |
| 08/10/2006 | US20060177511 Antiseptic compositions and methods |
| 08/10/2006 | US20060177508 Fast disintegrating tablet |
| 08/10/2006 | US20060177500 Solid dispersion of tacrolimus |
| 08/10/2006 | US20060177495 Polymer-lipid delivery vehicles |
| 08/10/2006 | US20060177492 Collagen gel and process of producing the same |
| 08/10/2006 | US20060177484 Cheese alternative product and process for preparing a cheese alternative product |
| 08/10/2006 | US20060177481 Methods for forming regional tissue adherent barriers and drug delivery systems |
| 08/10/2006 | US20060177457 Are designed to produce both Type 1 and Type 2 phototherapeutic effect at once using dual wavelength light source that will produce singlet oxygen and free radicals at the lesion of interest; for dual phototherapy of tumors and other lesions |
| 08/10/2006 | US20060177423 Composition and method for killing of tumours |
| 08/10/2006 | US20060177417 Packaged form containing complex of polypeptide and macromolecular carrier |
| 08/10/2006 | US20060177414 Pharmaceutical preparations for oral adminstration, containing ion-exchange resins loaded with active ingredients and intrinsically viscous gelling agents as thickening agents |
| 08/10/2006 | US20060177402 Synthetic tear fluid |
| 08/10/2006 | US20060177382 Delivery of antiemetics through an inhalation route |
| 08/10/2006 | US20060177373 Low density radionuclide-containing particulate material |
| 08/10/2006 | DE60024843T2 Impfstoffe zur oralen verwendung die liposomen sowie eine nukleinsäure enthalten Containing vaccines for oral use the liposome and a nucleic acid |
| 08/10/2006 | DE102005005542A1 Preparing interleukin-2 (IL-2) for pharmaceutical use, by adding sodium dodecyl sulfate to composition comprising IL-2, removing precipitated covalently-linked IL-2 multimers, and reducing sodium dodecyl sulfate concentration |
| 08/10/2006 | CA2830588A1 Conjugation of streptococcal capsular saccharides |
| 08/10/2006 | CA2829533A1 Contact drug delivery system |
| 08/10/2006 | CA2596683A1 Conjugation of streptococcal capsular saccharides |
| 08/10/2006 | CA2595904A1 Blys fusion proteins for targeting blys receptor and methods for treatment of b-cell proliferative disorders |
| 08/10/2006 | CA2594970A1 Conjugates of a polypeptide and a pentasaccharide |
| 08/10/2006 | CA2594636A1 Anti-ephb2 antibodies and methods using same |
| 08/10/2006 | CA2593908A1 Process for the preparation of polymer conjugates |
| 08/09/2006 | EP1688481A1 Bifidobacterium in the treatment of inflammatory disease |
| 08/09/2006 | EP1688432A1 Igm high concentration stabilized solution |
| 08/09/2006 | EP1688412A2 Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands |
| 08/09/2006 | EP1688169A1 Method for producing fine organic compound particles |
| 08/09/2006 | EP1688150A1 Process for the preparation of alkoxyamine functionalised poly ethylene glycols |
| 08/09/2006 | EP1688149A1 Paste formulations comprising silica |
| 08/09/2006 | EP1688146A1 Preparing aldesleukin for pharmaceutical use |
| 08/09/2006 | EP1688143A2 Niacin-containing substained-release tablets and kits |
| 08/09/2006 | EP1688134A2 Dry powder inhaler for transpulmonary administration |
| 08/09/2006 | EP1688133A1 Freeze-dried composition for transpulmonary administration |
| 08/09/2006 | EP1687267A2 Modified mscl protein channel |
| 08/09/2006 | EP1687031A1 Pharmaceutical preparation containing an antibody for the egf receptor |
| 08/09/2006 | EP1687028A2 Immunoglobulin preparations having increased stability |
| 08/09/2006 | EP1687026A1 Method for the treatment of multiple sclerosis by inhibiting il-17 activity |
| 08/09/2006 | EP1687024A2 Carbohydrate antigen-nanoparticle conjugates and uses thereof as antimetastatic agents in treating cancer |
| 08/09/2006 | EP1687019A2 Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices |
| 08/09/2006 | EP1687012A1 Stabilisation of viral microparticles |
| 08/09/2006 | EP1686972A1 Sprayable composition for the administration of vitamin d derivatives |
| 08/09/2006 | EP1686960A2 Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same |
| 08/09/2006 | EP1686959A2 Pharmaceutical formulations employing short-chain sphingolipids and their use |
| 08/09/2006 | EP1575559B1 Dosing aerosols containing lecithin as a surface-active substance |
| 08/09/2006 | EP1458387B1 Orodispersible tablets containing fexofenadine |
| 08/09/2006 | EP1390138B1 Vegetable protein-based microcapsules |
| 08/09/2006 | EP1383483A4 Controlled delivery of tetracycline compounds and tetracycline derivatives |
| 08/09/2006 | EP1372741B1 Morpholino imaging and therapy |
| 08/09/2006 | EP1363637B1 Pyrimidine compounds and methods for their preparation |
| 08/09/2006 | EP1221940B1 Liposome formulation of 6,9-bis- (2-aminoethyl)-amino|benzo g|isoquinoline-5,10-dione dimaleate |
| 08/09/2006 | EP1183275B1 Specific antibodies against human chorionic gonadotropin and their use in therapy and diagnostic |
| 08/09/2006 | EP1178782B1 Transdermal therapeutic system (tts) containing tolterodine |
| 08/09/2006 | EP1177197B1 Polyamines and their use in therapy |
| 08/09/2006 | EP1133319B1 Photosensitizer conjugates for targeting intracellular pathogens |
| 08/09/2006 | EP0981607B1 Modified arginine deiminase |
| 08/09/2006 | EP0951472B1 Peptide compositions with growth factor-like activity |
| 08/09/2006 | EP0827513B1 Reagents for treatment and diagnostic visualisation, particularly in cancer |
| 08/09/2006 | EP0752004B1 Recombinant adenoviruses coding for glial-derived neurotrophic factor (gdnf) |
| 08/09/2006 | CN1816564A Rasgap derived peptide for selectively killing cancer cells |
| 08/09/2006 | CN1816562A Protein achieving improved blocking efficiency |
| 08/09/2006 | CN1816356A Drug conjugate composition |